Background: Prevalence estimates of rheumatoid arthritis (RA) vary across Europe. Recent
estimates in southern European countries showed a lower prevalence than in northern …

Objective: To estimate the prevalence of spondyloarthropathies (SpAs) in France in a
multiregional representative sample in the year 2001. Methods: A two stage random sample was …

The chief aim is to contribute to the improvement of outcome of patients with rheumatic disorders.
Apart from the projects devoted to education and research, projects aimed at facilitating …

Osteoporosis constitutes a major worldwide public health burden characterized by enhanced
skeletal fragility. Bone metabolism is the combination of bone resorption by osteoclasts …

Importance One-third of patients with rheumatoid arthritis show inadequate response to tumor
necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment exists. …

OBJECTIVE: The objective of this study was to determine the time to relapse after tumor
necrosis factor α (TNFα) antagonist discontinuation in patients with remission of rheumatoid …

Objectives Rheumatoid arthritis (RA) patients are at an increased risk of developing comorbid
conditions. A close monitoring of the disease targeting a status of low disease activity is …

OBJECTIVE: To determine geographical variation in the prevalence of rheumatoid arthritis (RA)
and spondyloarthropathies (SpA) in France. METHODS: The survey sample was drawn …

Objective Continuous treatment with the anti–tumor necrosis factor α (anti‐TNFα) antibody
infliximab is efficacious in ankylosing spondylitis (AS), whereas treatment discontinuation …

Objective To evaluate the efficacy and tolerability of a single intraarticular (IA) injection of
hyaluronic acid (HA) for the treatment of hip osteoarthritis (OA). Methods A multicenter, …